相关实验视频
Updated: Jan 18, 2026

13:58
Peptide:MHC Tetramer-based Enrichment of Epitope-specific T cells
Published on: October 22, 2012
18.6K
在MPER/脂质体疫苗中,异种免疫调节了辅助和MPER细分之间的B细胞表位竞争
Rafiq Ahmad Khan1,2, Junjian Chen1,2,3,4, Luke Donius1,2,5
1Laboratory of Immunobiology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
NPJ vaccines
|January 16, 2026
概括
开发有效的HIV-1疫苗是具有挑战性的,因为亚主导的B细胞反应. 膜近端外部区域 (MPER) 疫苗的异质增强增强了对HIV-1的抗体亲和力和功能.
科学领域:
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
背景情况:
- 亚主导B细胞对保存表位的反应阻碍了对HIV-1的广泛中和抗体 (bnAb) 的发展.
- 艾滋病毒-1 gp41的膜近端外部区域 (MPER) 是一个保存的目标,但在病毒表面上部分被封闭.
研究的目的:
- 调查异质增强对MPER特异性B细胞反应的影响.
- 了解免疫策略如何克服诱导bnAbs抗HIV-1的局限性.
主要方法:
- 一种MPER/脂质体疫苗被设计成一个CD4 T细胞辅助表位.
- 免疫接种涉及初级疫苗接种,随后进行异质增强.
- 分析了B细胞反应,抗体亲和力和血抗体功能.
主要成果:
- 初级免疫引发了低亲和度的MPER特异性B细胞.
- 异质增强促进了MPER特异性B细胞扩张和增强抗体功能.
- 增加B细胞对MPER的亲和力,减少辅助表位特异性B细胞的竞争.
结论:
- 异质增强是一种可行的策略,可以增强MPER特异性B细胞反应和抗体功能.
- 起始抗原显著影响后续的MPER抗体反应.
- 这些发现为开发针对HIV-1等突变病毒的免疫策略提供了见解.
相关概念视频
Antigens Involved in Adaptive Immunity
1.3K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.3K
Cross-reactivity
32.9K
Overview
32.9K
B Cell Activation and Differentiation
16.1K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
16.1K
Hybridoma Technology
17.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.3K
Diversity of Antigen Receptors
1.4K
Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
1.4K

